ReviewFrontiers in immunology2021

The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer.

Sijia Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.